US ▾
HYFT
Earnings call · Jul 2026 (Q1 FY27)

MindWalk Holdings Q1 FY27 earnings call HYFT

Sep 14, 2026 Source

Executive summary

MindWalk Holdings Corp. Q1 FY27 — ReefIQ Launch & Strategic Platform Shift

MindWalk advanced its bio-native AI drug discovery goals in Q1 FY27, marked by the launch of its ReefIQ platform and a strategic shift towards broader platform partnerships. While significant investment in commercial infrastructure led to higher losses, the company secured a $30 million credit facility to fund growth without equity dilution. Management is focused on converting ongoing large pharma engagements for ReefIQ into recurring revenue, which is expected to be lumpy initially.

Highlights

5

  • Revenue grew 21% year-over-year to $3.8 million CAD, marking 5 consecutive quarters of YoY growth.

  • Gross margin expanded significantly to 59% in Q1 FY27 from 48% in the prior year.

  • Secured a binding commitment for a $30 million USD unsecured revolving credit facility at a fixed 7% rate, providing financial flexibility without equity dilution.

  • Successfully launched the proprietary ReefIQ data platform in June, engaging multiple large pharmaceutical companies in enterprise deployment discussions.

  • Shifted commercial strategy to broader platform partnerships, with approximately 80% of the current commercial funnel by value now structured this way.

Concerns

4

  • Net loss from continuing operations increased to $6.1 million CAD in Q1 FY27, compared to $4.1 million CAD in the prior year, reflecting deliberate investment.

  • Sales and marketing expenses significantly increased to $3.2 million CAD from $1.3 million CAD in the prior year, driven by planned commercial infrastructure investments.

  • R&D expenses rose to $1.3 million CAD from $1.0 million CAD year-over-year, primarily due to increased salary costs.

  • Revenue growth is expected to be relatively lumpy over the next 12-24 months due to the milestone-based nature of initial ReefIQ agreements.

Guidance & targets

CategoryTargetConfidence
Revenue growth
relatively lumpy
medium materiality
Low
Revenue growth
relatively lumpy
medium materiality
Low

Product announcements

ProductTypeDetails
ReefIQlaunch
OpenFold 3 on AMD Instinct MI325X GPUsmilestone

Deals & partnerships

AMD and Vultr Engineering partnership for OpenFold 3 deployment

Partnership to validate a production deployment of OpenFold 3 on AMD Instinct MI325X GPUs, enhancing compute capabilities for discovery and ReefIQ scaling.

Undisclosed financial institution Unsecured revolving credit facility $30 million USD

Binding commitment for a $30 million U.S. senior unsecured revolving credit facility at a fixed 7% rate, to be drawn as needed. The credit agreement is expected to be drawn up within 60 days.

Risks & headwinds

Increased net loss due to investment Q1 FY27

$6.1 million CAD net loss from continuing operations in Q1 FY27 vs $4.1 million CAD in Q1 FY26

Mitigation:Deliberate investment behind commercial opportunities and building a larger, more durable revenue base.

Lumpy revenue growth from new agreements next 12-24 months

Initial ReefIQ agreements are milestone-based, making revenue hard to forecast.

Mitigation:Focus on converting agreements to annual recurring revenue; management will provide more detail once agreements are announced.

IT security and data governance review for ReefIQ deployments ongoing

Not quantified, but a significant gating factor.

Mitigation:ReefIQ is designed to sit inside client's biological data and discovery workflows, undergoing enterprise security, data residency, and governance processes.

Legal and procurement negotiations for new contract shapes ongoing

Not quantified, but a significant gating factor.

Mitigation:Developing new multi-year platform relationship contracts that differ from historical project statements of work, requiring new procurement terms.

Scoping of initial ReefIQ deployments ongoing

Not quantified, but a significant gating factor.

Mitigation:Agreeing on which programs and data domains the first deployment will cover to ensure a clean landing and subsequent expansion.

What to watch in Q2 FY27

ReefIQ enterprise adoption

next quarter
Current multiple large pharmaceutical companies engaged in negotiations
Target announcement of specific partners or contract values

Why it matters

Conversion of these negotiations is key to validating the commercial opportunity and driving recurring revenue.

We are in active negotiations with multiple large pharma companies on ReefIQ enterprise deployments. You will hear from us as those conclude.

Q&A highlights

What portion of the $3.8 million Q1 revenue was from contracted recurring platform revenue, specifically ReefIQ or SaaS model subscriptions?

Management clarified that ReefIQ was just launched in June and is not yet contributing recurring revenue. They stated that SaaS model subscription revenue exists but is not broken out by cost centers.

“If it's recurring revenue or annual recurring revenue off of the SaaS model subscriptions, we do have that. We have announced that historically. I'm not sure that we have that broken out since we don't break these out by cost centers, but I can have Scott confirm.”

asked by Charles Wallace · answered by Jennifer Bath

2 min read 6 chapters

Detailed narrative

ReefIQ Platform Launch & Strategy

MindWalk launched its proprietary ReefIQ data platform in June, positioning it as a substrate layer that transforms complex, unstructured biological data into structured, biologically meaningful representations for AI models. The platform's commercial model is designed for multi-year recurring revenue relationships that scale with client usage. The company is actively engaged with multiple large pharmaceutical companies for potential enterprise deployments, noting that these opportunities are substantially larger than prior LensAI contracts.

Commercial Model Evolution

The company is reshaping its commercial relationships, moving from discrete projects to broader platform partnerships where MindWalk participates in the economics of assets it helps create. This structure aligns incentives with partners and has been well-received, contributing to increased activity in the commercial funnel. Approximately 80% of the current funnel by value is now structured this way, encompassing data management, ReefIQ, and multi-target discovery.

Strategic Partnerships & Infrastructure

MindWalk achieved a clear infrastructure milestone by validating a production deployment of OpenFold 3 on AMD Instinct MI325X GPUs, in partnership with AMD and Vultr. This enhancement provides more compute capacity for discovery and scaling ReefIQ. The company emphasizes that models commoditize, while the underlying layer compounds, and LensAI's model-neutral reasoning layer allows clients to integrate their own or third-party models over the same biological context.

Internal Pipeline Advancement

The internal pipeline continues to advance through preclinical development, with resources prioritized based on data strength. MindWalk added experienced leaders to accelerate IND-enabling work and move programs toward IND filings and the clinic. The company plans to provide market updates as these programs achieve scientific, regulatory, and development milestones.

Capital Structure & Financial Flexibility

MindWalk announced a binding commitment for a $30 million USD unsecured revolving credit facility at a fixed 7% rate, to be drawn as needed. This facility provides financial flexibility without issuing equity, which management views as crucial given the current stock valuation relative to AI-enabled discovery platforms. The capital will be used to invest in ReefIQ, advance the internal pipeline, and pursue other opportunities.

Client Engagement & Gating Factors for ReefIQ

Discussions with large pharmaceutical companies for ReefIQ enterprise deployments are ongoing, with gating factors varying significantly. Key areas include IT security and data governance review, legal and procurement negotiations for new multi-year platform contract shapes, and scoping the initial deployment to cover specific programs and data domains. Management noted that these are significant steps for clients bringing MindWalk into their core data infrastructure.

AI-generated summary of the company's earnings call. Not investment advice.